Skip to content
WeighLab

MEDVidi vs Aurelius Health Group

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

MEDVidi

Provider comparison

Patients who want weight-loss care bundled with an existing mental-health telehealth relationship.

Semaglutide / month
Not disclosed
Tirzepatide / month
Not disclosed
Index 52/100 · Grade CChecked October 2026

Aurelius Health Group

Provider comparison

Patients discussing a low-dose protocol with a clinician who understand that it is different from a full-dose weight-loss plan.

Semaglutide / month
Microdose GLP-1 program: $199/mo after $89 first month; molecule selected by provider
Tirzepatide / month
Microdose GLP-1 program: $199/mo after $89 first month; no full-dose price published
Index 49/100 · Grade CChecked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

MEDVidi has the higher Cost-Efficiency Index: 52/100 versus 49/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

MEDVidi
35 states
Aurelius Health Group
Coverage not published

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

MEDVidi

Aurelius Health Group

Semaglutide / month
MEDVidi: Not disclosed
Aurelius Health Group: Microdose GLP-1 program: $199/mo after $89 first month; molecule selected by provider
Tirzepatide / month
MEDVidi: Not disclosed
Aurelius Health Group: Microdose GLP-1 program: $199/mo after $89 first month; no full-dose price published
Semaglutide / year (modeled)
MEDVidi: —
Aurelius Health Group: —
Tirzepatide / year (modeled)
MEDVidi: —
Aurelius Health Group: —
State availability
MEDVidi: 35 states
Aurelius Health Group: Coverage not published
Oral / sublingual option listed
MEDVidi: Not listed
Aurelius Health Group: Not listed
Brand-name access listed
MEDVidi: Yes
Aurelius Health Group: Not confirmed
Provider facts checked
MEDVidi: October 2026
Aurelius Health Group: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

MEDVidi

Patients who want weight-loss care bundled with an existing mental-health telehealth relationship.

Reasons to consider it

  • Prescribes real branded GLP-1s (Wegovy, Zepbound) rather than only compounded alternatives
  • Transparent, flat consultation pricing ($195 initial, $159 follow-up, $249 bundled)
  • Broad multi-condition platform may suit patients with comorbid mental-health needs

What to weigh up

  • No medication pricing disclosed anywhere -- true monthly cost is unknowable before booking
  • Weight loss is a secondary service bolted onto a psychiatry-focused platform, not a core specialty
  • No named medical director or clinical leadership

Aurelius Health Group

Patients discussing a low-dose protocol with a clinician who understand that it is different from a full-dose weight-loss plan.

Reasons to consider it

  • Publishes the $89 introductory month and $199 ongoing program price
  • Physician consultations, monitoring and secure messaging are included
  • The FAQ describes semaglutide and tirzepatide microdose options

What to weigh up

  • This is a microdose program; the price does not establish a full-dose treatment cost
  • The $89 introductory figure applies only to the first month
  • State eligibility is confirmed during intake

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

MEDVidiAurelius Health Group
Normalized Cost/Month
MEDVidi:
45/100
Aurelius Health Group:
45/100
Price Transparency
MEDVidi:
30/100
Aurelius Health Group:
54/100
Nationwide Access
MEDVidi:
66/100
Aurelius Health Group:
24/100
Formulation Options
MEDVidi:
53/100
Aurelius Health Group:
40/100
Clinical Oversight
MEDVidi:
74/100
Aurelius Health Group:
81/100
Contract Flexibility
MEDVidi:
55/100
Aurelius Health Group:
61/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

More provider matchups
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.